Trinity Biotech TRIB Stock
Trinity Biotech Price Chart
Trinity Biotech TRIB Financial and Trading Overview
Trinity Biotech stock price | 0.54 USD |
Previous Close | 1.06 USD |
Open | 1.02 USD |
Bid | 0 USD x 1800 |
Ask | 0 USD x 1200 |
Day's Range | 1.02 - 1.05 USD |
52 Week Range | 0.8 - 1.5 USD |
Volume | 10.53K USD |
Avg. Volume | 42.46K USD |
Market Cap | 39.74M USD |
Beta (5Y Monthly) | 1.41338 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.25 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | June 5, 2015 |
1y Target Est | 4 USD |
TRIB Valuation Measures
Enterprise Value | 105.74M USD |
Trailing P/E | N/A |
Forward P/E | -4.7272725 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.53137785 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.414 |
Enterprise Value/EBITDA | -11.106 |
Trading Information
Trinity Biotech Stock Price History
Beta (5Y Monthly) | 1.41338 |
52-Week Change | -18.11% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.5 USD |
52 Week Low | 0.8 USD |
50-Day Moving Average | 0.97 USD |
200-Day Moving Average | 1.09 USD |
TRIB Share Statistics
Avg. Volume (3 month) | 42.46K USD |
Avg. Daily Volume (10-Days) | 68.68K USD |
Shares Outstanding | 38.21M |
Float | 21.74M |
Short Ratio | 0.8 |
% Held by Insiders | 35.65% |
% Held by Institutions | 17.22% |
Shares Short | 22.53K |
Short % of Float | N/A |
Short % of Shares Outstanding | 0.059% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -54.84% |
Operating Margin (ttm) | -14.60% |
Gross Margin | 29.48% |
EBITDA Margin | -12.73% |
Management Effectiveness
Return on Assets (ttm) | -6.46% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 74.78M USD |
Revenue Per Share (ttm) | 2.22 USD |
Quarterly Revenue Growth (yoy) | -7.59% |
Gross Profit (ttm) | N/A |
EBITDA | -9521000 USD |
Net Income Avi to Common (ttm) | -41002000 USD |
Diluted EPS (ttm) | -1.26 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 6.58M USD |
Total Cash Per Share (mrq) | 0.17 USD |
Total Debt (mrq) | 72.2M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 2.692 |
Book Value Per Share (mrq) | -0.057 |
Cash Flow Statement
Operating Cash Flow (ttm) | -921000 USD |
Levered Free Cash Flow (ttm) | -8472750 USD |
Profile of Trinity Biotech
Country | United States |
State | N/A |
City | Bray |
Address | IDA Business Park |
ZIP | A98 H5C8 |
Phone | 353 1 276 9800 |
Website | https://www.trinitybiotech.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 398 |
Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.
Q&A For Trinity Biotech Stock
What is a current TRIB stock price?
Trinity Biotech TRIB stock price today per share is 0.54 USD.
How to purchase Trinity Biotech stock?
You can buy TRIB shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Trinity Biotech?
The stock symbol or ticker of Trinity Biotech is TRIB.
Which industry does the Trinity Biotech company belong to?
The Trinity Biotech industry is Diagnostics & Research.
How many shares does Trinity Biotech have in circulation?
The max supply of Trinity Biotech shares is 19.19M.
What is Trinity Biotech Price to Earnings Ratio (PE Ratio)?
Trinity Biotech PE Ratio is now.
What was Trinity Biotech earnings per share over the trailing 12 months (TTM)?
Trinity Biotech EPS is -2.25 USD over the trailing 12 months.
Which sector does the Trinity Biotech company belong to?
The Trinity Biotech sector is Healthcare.
Trinity Biotech TRIB included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
NASDAQ Composite Total Return I XCMP | 19079.55 USD — |
-5.82
|
— — | 19064.73 USD — | 19740.96 USD — | — - | — — |
NASDAQ Global Select Market Com NQGS | 7625.89 USD — |
-5.84
|
— — | 7621.56 USD — | 7894.21 USD — | — - | — — |
NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}